- Location
IFN
"-
Elderly Kidney Cancer Patients Benefit From Sunitinib Therapy
Feb 27, 2014By Sara Freeman, medwireNews Reporter Elderly kidney cancer patients benefit from sunitinib therapy just as much as their younger counterparts, a retrospective analysis of six clinical trials shows. Median progression-free survival ...
Tags: PFS, mRCC, Advanced Age, IFN
-
Avian H7N9 Influenza Virus Has Caused More Than 130 Human Infections with 43 Deaths
Jan 16, 2014The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this ...
Tags: Influenza Virus, H7N9, Health, Medicine
-
Medical Center Study Has Found a Way to Boost The Corneal Transplant Acceptance Rate
Jan 3, 2014For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to ...
Tags: corneal transplant, UT Southwestern Medical Center, interferon-gamma
-
Gilead Sciences Has Received Notice of Compliance From Health Canada
Dec 19, 2013Gilead Sciences has received notice of compliance from Health Canada for its once-daily oral nucleotide analog polymerase inhibitor Sovaldi or sofosbuvir 400mg tablets for the treatment of chronic hepatitis C or CHC infection. Sovaldi is ...
-
FDA Has Approved Sovaldi 400mg Tablets
Dec 10, 2013Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...
Tags: Gilead Sciences, Chronic Hepatitis
-
Gilead Obtained Priority Review Status for Sofosbuvir New Drug Application
Jun 13, 2013Biopharmaceutical company Gilead Sciences has obtained priority review status for Sofosbuvir new drug application (NDA) from the FDA for the treatment of hepatitis C infection (HCV). The investigational product is an oral nucleotide ...
Tags: Gilead, Sofosbuvir NDA
-
IFN to Deliver IP Networking/SAN Solutions to End Customers
Dec 28, 2012IFN to Deliver IP Networking/SAN Solutions to End Customers Indiana Fiber Network (IFN) today announced that it has joined the Brocade Alliance Partner Network (APN) program. IFN will deliver solutions and services around Brocade storage ...
Tags: IFN, Computer Products, Brocade Alliance, Partner Network
-
IFN-Holding Intends to Invest Roughly €40m in 2012
Dec 18, 2012The Austrian company IFN-Holding intends to invest roughly €40m in 2012 in new technologies, products and the expansion of its business locations. Most of that amount, at roughly €30m, will go to the expansion of window production ...
Tags: IFN-Holding, Austrian, investment
-
EC Has Granted a €6m Grant to The "FIGHT HLH" Consortium
Nov 29, 2012The European Commission (EC) has granted a €6m grant to the "FIGHT HLH" consortium of institutions to support clinical testing of NovImmune's anti-interferon gamma drug candidate, NI-0501. The FIGHT HLH consortium lead by NovImmune ...
